Eishlon Pharmacon Private Limited

Pharmaceutical trading company established in 2018, based in Haryana.

2018 | Ambala, Haryana (India) | Active
Last Updated:

Eishlon Pharmacon Profile

Key Indicators

  • Authorised Capital ₹ 7.50 M
  • Paid Up Capital ₹ 7.50 M
  • Company Age 7 Year, 21 Days
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth 7.57%
  • Profit Growth -81.53%
  • Ebitda -44.76%
  • Net Worth 0.91%
  • Total Assets 47.61%

About Eishlon Pharmacon

Eishlon Pharmacon Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 February 2018 (Seven years 21 days old ). Its registered office is in Ambala, Haryana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M, as per Ministry of Corporate Affairs (MCA) records.

Ashok Kumar, Ankit Agrawal, Usha Agrawal, and Two other members serve as directors at the Company.

Company Details

  • Location

    Ambala, Haryana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U74999HR2018PTC072646

  • Company No.

    072646

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    20 Feb 2018

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma
Company report

Eishlon Pharmacon Private Limited

Explore comprehensive data for Eishlon Pharmacon Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Eishlon Pharmacon?

Board Members (5)

NameDesignationAppointment DateStatus
Ashok Kumar Country flag representing In Director 13-Aug-2018Current
Ankit Agrawal Country flag representing In Director 20-Feb-2018Current
Usha Agrawal Country flag representing In Director 17-Sep-2018Current
Ronit Kumar Country flag representing In Director 20-Feb-2018Current
Preeti Agrawal Country flag representing In Director 17-Sep-2018Current

Financial Performance of Eishlon Pharmacon.

Eishlon Pharmacon Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.57% increase. The company also saw a substantial fall in profitability, with a 81.53% decrease in profit. The company's net worth moved up by a moderate rise of 0.91%.

Eishlon Pharmacon revenue growth over time
Eishlon Pharmacon profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
7.57%
Revenue from Operations
7.57%
Total Assets
47.61%
Profit or Loss
-81.53%
Net Worth
0.91%
EBITDA
-44.76%

What is the Ownership and Shareholding Structure of Eishlon Pharmacon?

Unlock access to Eishlon Pharmacon's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Eishlon Pharmacon?

Unlock and access historical data on people associated with Eishlon Pharmacon, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Eishlon Pharmacon Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eishlon Pharmacon, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eishlon Pharmacon's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Eishlon Pharmacon

Recent activity within the organization

  • Annual General Meeting

    Eishlon Pharmacon Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Eishlon Pharmacon Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.

  • Director Appointment

    Usha Agrawal was appointed as a Director was appointed as a Director on 17 Sep 2018 & has been associated with this company since 6 years 5 months .

  • Director Appointment

    Preeti Agrawal was appointed as a Director was appointed as a Director on 17 Sep 2018 & has been associated with this company since 6 years 5 months .

  • Director Appointment

    Ashok Kumar was appointed as a Director was appointed as a Director on 13 Aug 2018 & has been associated with this company since 6 years 7 months .

  • Director Appointment

    Ankit Agrawal was appointed as a Director was appointed as a Director on 20 Feb 2018 & has been associated with this company since 7 years 21 days .

Frequently asked questions

  • What is the Incorporation or founding date of Eishlon Pharmacon Private Limited?

    Eishlon Pharmacon Private Limited was incorporated on 20 Feb 2018.

  • What is authorized share capital and paid-up capital of Eishlon Pharmacon Private Limited?

    The authorized share capital of Eishlon Pharmacon Private Limited is ₹ 7.50 M and paid-up capital is ₹ 7.50 M.

  • Who are the current board members & directors of Eishlon Pharmacon Private Limited?

    Currently 5 directors are associated with Eishlon Pharmacon Private Limited.

    • Ashok Kumar
    • Ankit Agrawal
    • Usha Agrawal
    • Ronit Kumar
    • Preeti Agrawal
  • What is the registered address of Eishlon Pharmacon Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Eishlon Pharmacon Private Limited is Shop No. 45 Vita Enclave India, Ambala City, Haryana, 134003.

  • What is the corporate identification number (CIN) and company number of Eishlon Pharmacon Private Limited?

    The corporate identification number (CIN) of Eishlon Pharmacon Private Limited is U74999HR2018PTC072646 and the company number is 072646 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Eishlon Pharmacon Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Eishlon Pharmacon Private Limited has risen by 7.57%.

  • What change has been observed in the net worth of Eishlon Pharmacon Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Eishlon Pharmacon Private Limited has experienced an upsurge of 0.91%.

  • When was the last Balance Sheet of Eishlon Pharmacon Private Limited filed with the ROC?

    The most recent Balance Sheet for Eishlon Pharmacon Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed